Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Barinthus Biotherapeutics Plc ADR (BRNS)

Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,011
  • Shares Outstanding, K 39,033
  • Annual Sales, $ 800 K
  • Annual Income, $ -73,350 K
  • 60-Month Beta -0.53
  • Price/Sales 60.94
  • Price/Cash Flow N/A
  • Price/Book 0.32
Trade BRNS with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.45
  • Number of Estimates 2
  • High Estimate -0.41
  • Low Estimate -0.49
  • Prior Year -0.37
  • Growth Rate Est. (year over year) -21.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1100 +13.06%
on 09/05/24
1.4400 -12.85%
on 09/09/24
-0.0850 (-6.34%)
since 08/12/24
3-Month
1.1100 +13.06%
on 09/05/24
1.9350 -35.14%
on 06/13/24
-0.6450 (-33.95%)
since 06/12/24
52-Week
1.1100 +13.06%
on 09/05/24
5.1000 -75.39%
on 11/06/23
-0.5950 (-32.16%)
since 09/12/23

Most Recent Stories

More News
Fed Speaks, Canada Inflation on Lineup Next Week

Monday U.S. Economic Lookahead Home builder confidence index (Feb.) Featured Earnings ...

AOT.TO : 0.1620 (+1.25%)
FLOW.TO : 0.1900 (unch)
SMT.TO : 0.69 (+4.55%)
DD : 80.48 (+0.71%)
CNM : 39.76 (+2.47%)
HQY : 76.77 (+2.16%)
HUMA : 5.59 (-1.76%)
BRNS : 1.2600 (+2.44%)

Business Summary

Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases. The company's product pipeline includes VTP-300, VTP-200, VTP-1000, VTP-850 and VTP-1100. Barinthus...

See More

Key Turning Points

3rd Resistance Point 1.3217
2nd Resistance Point 1.3033
1st Resistance Point 1.2667
Last Price 1.2600
1st Support Level 1.2117
2nd Support Level 1.1933
3rd Support Level 1.1567

See More

52-Week High 5.1000
Fibonacci 61.8% 3.5758
Fibonacci 50% 3.1050
Fibonacci 38.2% 2.6342
Last Price 1.2600
52-Week Low 1.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar